相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting of the tumor immune microenvironment by metformin
Zihong Wu et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2022)
Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?
Nadiya Hussain et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Impact of Renin-angiotensin System Inhibitors on the Efficacy of Anti-PD-1/PD-L1 Antibodies in NSCLC Patients
Takehiro Tozuka et al.
ANTICANCER RESEARCH (2021)
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Alessio Cortellini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Effect of angiotensin II inhibition on non-small cell lung cancer response to immune checkpoint blockers
P. M. Pereira et al.
ANNALS OF ONCOLOGY (2021)
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy
Sebastiano Buti et al.
EUROPEAN JOURNAL OF CANCER (2021)
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials
Francesco Massari et al.
EUROPEAN JOURNAL OF CANCER (2021)
Therapeutic Repurposing of Biguanides in Cancer
Hongyun Zhao et al.
TRENDS IN CANCER (2021)
Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors
Louis Gaucher et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials
M. Chalabi et al.
ANNALS OF ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer
A. Iglesias-Santamaria
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitors
Shipra Gandhi et al.
IMMUNOTHERAPY (2020)
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β
Alessandra Metelli et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer
Martin Svaton et al.
ANTICANCER RESEARCH (2020)
Metformin Enhances the Antitumor Activity of CD8+ T Lymphocytes via the AMPK-miR-107-Eomes-PD-1 Pathway
Zhen Zhang et al.
JOURNAL OF IMMUNOLOGY (2020)
Manipulation of Metabolic Pathways and Its Consequences for Anti-Tumor Immunity: A Clinical Perspective
Huang-Yu Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Impact of angiotensin II pathway inhibition on tumor response to anti PD(L)1 based therapy
J. Strauss et al.
EUROPEAN JOURNAL OF CANCER (2020)
Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysis
Francesco Massari et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
Alessio Cortellini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers
Soleine Medjebar et al.
ONCOIMMUNOLOGY (2020)
Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study
Sarbajit Mukherjee et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Exploring the emerging role of the microbiome in cancer immunotherapy
Jessica Fessler et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey
Colin W. O'Brien et al.
ANNALS OF INTERNAL MEDICINE (2019)
Cutting Edge: Targeting Thrombocytes to Rewire Anticancer Immunity in the Tumor Microenvironment and Potentiate Efficacy of PD-1 Blockade
Brian P. Riesenberg et al.
JOURNAL OF IMMUNOLOGY (2019)
Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications
Biagio Ricciuti et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
Giovanni Fuca et al.
ESMO OPEN (2019)
Clinical outcomes in non-small-cell lung cancer patients receiving concurrent metformin and immune checkpoint inhibitors
Muhammad Z. Afzal et al.
LUNG CANCER MANAGEMENT (2019)
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
Muhammad Zubair Afzal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Kathryn C. Arbour et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong-Ho Cha et al.
MOLECULAR CELL (2018)
Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice
Andrea V. Fuentes et al.
PHARMACY (2018)
Safety and Tolerability of PD-1/PD-L1 Inhibitors Compared with Chemotherapy in Patients with Advanced Cancer: A Meta-Analysis
Tomohiro F. Nishijima et al.
ONCOLOGIST (2017)
Aspirin in the era of immunotherapy
Tsuyoshi Hamada et al.
ONCOTARGET (2017)
What is polypharmacy? A systematic review of definitions
Nashwa Masnoon et al.
BMC GERIATRICS (2017)
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Saleh Rachidi et al.
SCIENCE IMMUNOLOGY (2017)
Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma
Jarrett J. Failing et al.
MELANOMA RESEARCH (2016)
Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis
Mizuki Nishino et al.
JAMA ONCOLOGY (2016)
Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer
Xuesong Chen et al.
CANCER LETTERS (2013)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
分享论文
